The COVID-causing virus SARS-CoV-2 harbors a vulnerable site at the base of its spike protein that is found also on closely related coronaviruses, according to a new study from Scripps Research. The discovery, published in Science Translational Medicine, could inform the design of broad-acting vaccines and antibody therapies capable of stopping future coronavirus pandemics.
Scientists identified vulnerable site on multiple coronaviruses
February 10, 2022
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022